Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Increased levels of NT-proBNP are known to increase the risk of cardiac events in diabetic
patients. The other way around, patients with normal values have an excellent prognosis on
short-term. We intend in our study to proof the hypothesis, whether it is possible to
decrease NT-proBNP levels by intensified cardiac prevention care We aim those patients, who
already have elevated levels, although no history of a cardiac disease. This decrease in
NT-proBNP should be translated consequently in a decrease in cardiac events